Bryxta 400 Mg Injection

Name: Bryxta 400 Mg Injection
Brand: PATHGENE PHARMA DISTRIBUTORS
Price: 10500 INR
Availability: InStock

Price 10500 INR/ Vial

Get a Price/Quote

MOQ : 50 Vials

Bryxta 400 Mg Injection Specification

Indication
Cancer treatment (various types)

Salt Composition
Bevacizumab

Dosage Form
Injection

Enzyme Types
Not applicable (monoclonal antibody)

Feature
Anti-cancer monoclonal antibody

Ingredients
Bevacizumab

Application
For intravenous infusion

Physical Color/Texture
Clear liquid

Fermentation Smell
Odorless

Enzymatic Activity
No enzymatic activity

Storage Instructions
Store in a refrigerator (2C-8C). Do not freeze.

Shelf Life
As per package insert

Strength
400 mg/16 ml

Prescription
Required

Unit Pack
1 vial per box

Type
Biological

Route
Intravenous

Dilution
Required before use

Packaging Type
Box

Bryxta 400 Mg Injection Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Vials Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About Bryxta 400 Mg Injection

Discover the fresh approach to cancer therapy with Bryxta 400 Mg Injection, an imposing, premier treatment option for various cancers. Crafted using the illustrious anti-cancer monoclonal antibody, Bevacizumab, this new formulation comes in a 400 mg/16 ml vial, requiring prescription and dilution before intravenous infusion. Each box contains a single sterile vial, housed in a secure package. As an advanced biological treatment, Bryxta delivers targeted intervention, helping slow tumor growth. Store refrigerated (2C-8C), never frozen, ensuring safety and efficacy until the ending soon shelf life.

Surface Application and Usage Specifics

Bryxta 400 Mg Injection is designed for intravenous administration under medical supervision, making it suitable for institutional or hospital use. The usage type is strictly prescription-based, with professional preparation and dilution required before infusion. This premier monoclonal antibody therapy is tailored for the treatment of various cancers, offering targeted intervention and improved management outcomes for eligible patients. It is intended for single-use per vial, supporting precise and safe dosage during each session.

Certifications, Market & Packaging Details: Drop-Off and Delivery

Bryxta 400 Mg Injection meets stringent regulatory certifications for medical use in India's main domestic market. Each unit is safely packaged in a robust box, with one vial per package to maintain product integrity during transit. Items are typically handed over to trusted medical suppliers or delivered directly to authorized healthcare facilities, ensuring secure drop-off and adherence to storage requirements-refrigerated at 2C-8C-to preserve the fresh, clear liquid formulation.

FAQ's of Bryxta 400 Mg Injection:

Q: How is Bryxta 400 Mg Injection administered?

A: Bryxta 400 Mg Injection is administered as an intravenous infusion, which must be diluted and given under the supervision of a healthcare professional.

Q: What benefits does Bryxta 400 Mg Injection offer in cancer treatment?

A: Bryxta 400 Mg Injection utilizes an anti-cancer monoclonal antibody, Bevacizumab, to help inhibit tumor growth and progression in various types of cancers, making it a premier choice for targeted therapy.

Q: When should the Bryxta 400 Mg Injection be used?

A: Bryxta 400 Mg Injection should be used only when prescribed by an oncologist, following a cancer diagnosis and tailored treatment plan.

Q: Where should Bryxta 400 Mg Injection be stored before use?

A: This injection should be stored in a refrigerator at a temperature of 2C-8C and must not be frozen to maintain its efficacy.

Q: What is the process for receiving and using Bryxta 400 Mg Injection?

A: The injection is delivered in a secure box, handed over to authorized healthcare providers, who will dilute and administer it as a single-use intravenous infusion in a controlled medical environment.